이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Innovent Biologics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

SEHK:1801 회사 또는 개인의 최근 내부자 거래
날짜	가치	이름	엔티티	공유	최대 가격
11 Sep 24	BuyHK$86,095	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	2,000	HK$43.05
11 Sep 24	BuyHK$86,095	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	Company	2,000	HK$43.05
11 Sep 24	SellHK$1,743,432	JP Morgan Asset Management	Company	40,500	HK$43.05
11 Sep 24	SellHK$666,472,087	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	15,482,177	HK$43.05
10 Sep 24	BuyHK$448,670,085	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	10,624,087	HK$42.23
10 Jul 24	SellHK$99,421,894	Capital Research and Management Company	Company	2,755,000	HK$36.09
03 May 24	SellHK$36,587,668	De-Chao Yu	Individual	906,250	HK$40.37
02 Feb 24	BuyHK$60,788,476	Capital Research and Management Company	Company	1,869,776	HK$32.51
12 Jan 24	BuyHK$51,892,586	Capital Research and Management Company	Company	1,292,500	HK$40.15
05 Jan 24	SellHK$133,714,368	Capital Research and Management Company	Company	3,456,000	HK$38.69
25 Oct 23	BuyHK$103,314,132	Capital Research and Management Company	Company	2,249,500	HK$45.93
17 Oct 23	SellHK$22,237,564	De-Chao Yu	Individual	502,961	HK$44.21
12 Oct 23	SellHK$143,016,662	Capital Research and Management Company	Company	3,324,500	HK$43.02

내부자 거래량

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.

소유권 분석

1801 의 소유 구조는 어떻게 되나요?
소유자 유형	공유 수	소유권 비율
민간 기업	10,614,500	0.651%
VC/PE 기업	89,475,350	5.49%
개인 내부자	114,734,823	7.03%
일반 대중	661,308,412	40.5%
교육기관	754,912,784	46.3%

주식의 희석: 지난 해 주주들은 의미 있게 희석되지 않았습니다.

최대 주주

상위 25 주주가 회사의 49.29%를 소유하고 있습니다.

소유권	이름	공유	현재 값	변경 %	포트폴리오 %
6.95%	Capital Research and Management Company	113,425,003	HK$5.3b	-0.65%	0.03%
6.76%	De-Chao Yu	110,253,778	HK$5.1b	0.92%	데이터 없음
5.49%	SDIC Innovation Investment Management Co., Ltd.	89,475,350	HK$4.2b	0%	35.66%
3.58%	The Vanguard Group, Inc.	58,440,486	HK$2.7b	0%	데이터 없음
3.39%	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	55,364,540	HK$2.6b	0%	53.37%
2.62%	BlackRock, Inc.	42,678,599	HK$2.0b	-1.42%	데이터 없음
2.23%	GF Fund Management Co., Ltd.	36,440,000	HK$1.7b	-17.1%	0.47%
1.99%	Norges Bank Investment Management	32,441,094	HK$1.5b	116%	0.01%
1.85%	Fidelity International Ltd	30,119,499	HK$1.4b	0%	0.07%
1.68%	E Fund Management Co., Ltd.	27,411,000	HK$1.3b	0%	0.22%
1.66%	Canada Pension Plan Investment Board	27,004,000	HK$1.3b	0%	0.04%
1.53%	Citigroup Inc.,Banking and Securities Investments	24,932,063	HK$1.2b	0%	0.11%
1.46%	Bosera Asset Management Co., Ltd.	23,872,000	HK$1.1b	-0.63%	0.68%
1.44%	Harvest Fund Management Co. Ltd.	23,421,288	HK$1.1b	-9.97%	0.32%
0.88%	Lav Advanced Management Company Limited	14,276,500	HK$665.3m	0%	81.73%
0.84%	FMR LLC	13,704,425	HK$638.6m	-11.3%	데이터 없음
0.77%	Temasek Holdings (Private) Limited	12,585,500	HK$586.5m	-57.7%	0.06%
0.62%	Schroder Investment Management Limited	10,080,000	HK$469.7m	0%	0.04%
0.61%	China Asset Management Co. Ltd.	9,881,751	HK$460.5m	-0.64%	0.08%
0.54%	Schroder Investment Management North America Inc.	8,744,500	HK$407.5m	0%	0.15%
0.52%	Polar Capital Holdings Plc	8,551,503	HK$398.5m	0%	0.18%
0.51%	ICBC Credit Suisse Asset Management Co., Ltd.	8,343,974	HK$388.8m	214%	0.27%
0.49%	Invesco Ltd.	8,029,000	HK$374.2m	-1.98%	0.01%
0.45%	LAV Investment Adviser Limited	7,345,000	HK$342.3m	0%	37.91%
0.43%	JPMorgan Chase & Co, Brokerage and Securities Investments	7,054,321	HK$328.7m	94.9%	0.02%